Skip to main content
. 2020 Nov 21;14(1):100954. doi: 10.1016/j.tranon.2020.100954

Table 1.

Univariate and multivariate logistic regression models in the development cohort.

Characteristic EGFR mutant (n = 159) EGFR wild-type (n = 143) Univariate analysis Multivariate analysis
OR (95%CI) P value OR (95%CI) P value
Age (years)
Mean ± SD 57.55±9.31 58.43±9.78 0.99
(0.97∼1.01)
0.421 NA
Sex,%
Male 58 (36.5) 90 (62.9) Reference <0.001 NA
Female 101 (63.5) 53 (37.1) 2.96
(1.85∼4.72)
Smoking history*,%
Yes 23 (14.5) 58 (40.6) Reference <0.001 Reference
No 136 (85.5) 85 (59.4) 0.25
(0.14∼0.43)
0.2 (0.1, 0.4) <0.001
CEA (μg/L),%
Normal 44 (27.7) 48 (33.6) Reference 0.267 NA
High 115 (72.3) 95 (66.4) 1.32
(0.81, 2.16)
Distribution,%
Central 38 (23.9) 40 (28.0) Reference 0.419 NA
Peripheral 121 (76.1) 103 (72.0) 1.24
(0.74∼2.07)
Lobe location,%
Right upper 45 (28.3) 41 (28.7) Reference 0.217 NA
Right middle 19 (11.9) 8 (5.6) 2.16
(0.86∼ 5.47)
Right lower 37 (23.3) 30 (21.0) 1.12
(0.59∼ 2.13)
Left upper 34 (21.4) 32 (22.4) 0.97
(0.51∼1.84)
Left lower 24 (15.1) 32 (22.4) 0.68
(0.35∼1.35)
Long-axis diameter 3.91±1.83 5.17±2.55 0.77
(0.69∼0.86)
<0.001 NA
Short-axis diameter 3.12±3.07 3.62±1.76 0.89
(0.78∼1.02)
0.098 NA
Size,%
≤ 3 cm 61 (38.4) 32 (22.4) Reference 0.003 NA
>3 cm 98 (61.6) 111 (77.6) 0.46
(0.28∼0.77)
Contour,%
Regular 68 (42.8) 38 (26.6) Reference 0.003 NA
Irregular 91 (57.2) 105 (73.4) 0.48
(0.30∼0.79)
Lobulation,%
≤ 3 75 (47.2) 52 (36.4) Reference 0.058 NA
>3 84 (52.8) 91 (63.6) 0.64
(0.40∼1.02)
Spiculation,%
Yes 120 (75.5) 80 (55.9) 2.42
(1.49∼ 3.95)
<0.001 NA
No 39 (24.5) 63 (44.1) Reference
Texture,%
Non-solid 36 (22.6) 27 (18.9) Reference 0.422 NA
Solid 123 (77.4) 116 (81.1) 0.80
(0.45∼1.39)
Air bronchogram,%
Yes 104 (65.4) 69 (48.3) 2.03
(1.28∼3.22)
0.003 NA
No 55 (34.6) 74 (51.7) Reference
Bubble-like lucency,%
Yes 103 (64.8) 57 (39.9) 2.78
(1.74∼4.43)
<0.001 2.2 (1.3, 3.8) 0.003
No 56 (35.2) 86 (60.1) Reference Reference
Calcification,%
Yes 24 (15.1) 36 (25.2) 0.53
(0.30∼0.94)
0.029 NA
No 135 (84.9) 107 (74.8) Reference
Vascular convergence,%
Yes 139 (87.4) 101 (70.6) 2.89
(1.60∼5.22)
<0.001 NA
No 20 (12.6) 42 (29.4) Reference
Fissure attachment,%
Yes 50 (31.4) 50 (35.0) 0.85
(0.53∼1.38)
0.517 NA
No 109 (68.6) 93 (65.0) Reference
Pleural attachment,%
Yes 42 (26.4) 71 (49.7) 0.36
(0.22∼0.59)
<0.001 0.4 (0.2, 0.7) 0.001
No 117 (73.6) 72 (50.3) Reference Reference
TABD,%
Yes 101 (63.5) 42 (29.4) 4.19
(2.58∼6.79)
<0.001 3.1 (1.8, 5.3) <0.001
No 58 (36.5) 101 (70.6) Reference
Peripheral emphysema,%
Yes 131 (82.4) 123 (86.0) 0.76
(0.41∼1.42)
0.390 NA
No 28 (17.6) 20 (14.0) Reference
Peripheral fibrosis,%
Yes 127 (79.9) 122 (85.3) 0.68
(0.37∼1.25)
0.215 NA
No 32 (20.1) 21 (14.7) Reference
Inflammation,%
Yes 110 (69.2) 101 (70.6) 0.93
(0.57∼ 1.53)
0.784 NA
No 49 (30.8) 42 (29.4) Reference
Pleural effusion,%
Yes 41 (25.8) 53 (37.1) 0.59
(0.36∼0.96)
0.035 NA
No 118 (74.2) 90 (62.9) Reference

CEA, carcinoembryonic antigen; EGFR, epidermal growth factor receptor; NA, not applicable; SD, standard deviation; TABD, Thickened adjacent bronchovascular bundles.

Smoking history is defined as follows: Yes, former and current smokers; No, never smoked.